CIDRAP newsletters options
The US Food and Drug Administration (FDA) today announced the approval of Recarbrio, a new three-drug antibacterial product developed by Merck, for treating patients with complicated urinary tract infections (cUTIs) and complicated intra-abdominal infections (cIAIs) caused by gram-negative pathogens.
The first case in Goma, North Kivu province's heavily populated capital, triggered reconsideration by the WHO's emergency committee.
In another development, Saudi Arabia today reported one new illness, which involves a man from Riyadh.
The number of confirmed and probable cases of the multidrug-resistant fungus Candida auris in the United States rose to 716 as of May 31, reflecting an increase of 32, the US Centers for Disease Control and Prevention (CDC) said in its most recent case-count update.
The World Health Organization (WHO) European regional office said yesterday that the region achieved 91% coverage for the second dose of measles vaccine, signifying the second consecutive year that the area has reached a record high.
Also, a high-level meeting was held in Geneva today to assess the latest developments and build donor support.
Researchers found C difficile spores quickly contaminate surgical gowns, cannot be killed by standard disinfectant.
For the second week in a row the Centers for Disease Control and Prevention (CDC) recorded 14 new measles cases across the United States, raising this year's total number of cases to 1,123 in 28 states.
It's a sign of slowing transmission in a record-breaking year, which has seen the most cases since 1992 and the most since the US eliminated measles in 2000.
Merck's rVSV-ZEBOV is the only vaccine that will be used during the ever-growing outbreak in North Kivu and Ituri provinces.
The Global Polio Eradication Initiative (GPEI) today reported nine new cases of wild poliovirus type 1 (WPV1), and, for the first time in more than a year, China has confirmed a case of vaccine-derived poliovirus.
In addition, Angola has a new circulating vaccine-derived poliovirus type 2 (cVDPV2) case.
A cost-effectiveness analysis indicates a Staphylococcus aureus decolonization protocol for patients undergoing hip and knee replacement could result in cost savings and fewer surgical-site infections (SSIs), Canadian researchers reported yesterday in Antimicrobial Resistance and Infection Control.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Antibiotic prescribing guided by C-reactive protein testing resulted in a lower rate of those drugs for COPD exacerbations in Britain.
The new cases raise the number of infected healthcare workers to 132, 68% of whom are nurses.
Researchers from Ontario followed more than 100,000 live births for 5 years after the 2009-10 flu season and found no adverse health outcomes in children exposed to prenatal 2009 pandemic (pH1N1) flu vaccination, according to a study yesterday in BMJ.
A survey of antimicrobial use reduction goals for human medicine in 30 countries has found that, as of 2017, less than a third had established targets, according to an article today in Eurosurveillance.
The agency says prompt reporting is key to help figure out the cause of the mysterious limb-weakening condition.
The idea is to delink profit from the volume sold, pay for antibiotics based on their public health value, and encourage development of new antibiotics.
CDC reverse-engineers the virus for important trials of interventions.
The rate of antibiotic prescribing and the proportion of patients receiving antibiotics in primary care settings in England declined consistently from 2014 through 2017, researchers from King's College London reported yesterday in BMJ Open.
